Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats

• Published in: Behavioural pharmacology Vol. 32; no. 6; p. 524
• Main Authors: Thomas, Angela M, Cargile, Kaley J, Lunn, Jannelle A, Baker, Lisa E
• Format: Journal Article
• Language: English
• Published: England 01.09.2021
• Subjects: Animals; Benzazepines - pharmacology; Benzodioxoles - pharmacology; Central Nervous System Stimulants - pharmacology; Cocaine - pharmacology; Dopamine Antagonists - pharmacology; Dopamine Uptake Inhibitors - pharmacology; Dose-Response Relationship, Drug; Female; Hallucinogens - pharmacology; N-Methyl-3,4-methylenedioxyamphetamine - pharmacology; Pyrrolidines - pharmacology; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 - antagonists & inhibitors; Receptors, Dopamine D1 - metabolism; Receptors, Dopamine D2 - analysis; Receptors, Dopamine D2 - metabolism; Sex Factors; Synaptic Transmission - physiology
• ISSN: 1473-5849
• DOI: 10.1097/FBP.0000000000000647

3,4-Methylenedioxypyrovalerone (MDPV), one of several synthetic cathinones, is a popular constituent of illicit 'bath salts'. In preclinical studies utilizing drug discrimination methods with male rodents, MDPV has been characterized as similar to both cocaine and 3,4-methylenedioxymethamphetamine-hydrochloride (MDMA). Whereas few drug discrimination studies have utilized female rats, the current study evaluated the discriminative stimulus effects of MDPV in 12 adult female Sprague-Dawley rats trained to discriminate 0.5 mg/kg MDPV from saline under a fixed ratio 20 schedule of food reinforcement. Stimulus substitution was assessed with MDPV and its enantiomers, other synthetic cathinones [alpha pyrrolidinopentiophenone-hydrochloride(α-PVP), 4-methylmethcathinone (4-MMC)], other dopamine agonists (cocaine, [+)-methamphetamine] and serotonin agonists [MDMA, lysergic acid diethylamide (LSD)] Stimulus antagonism was assessed with the dopamine D1 receptor antagonist, Sch 23390 and the D2 receptor antagonist, haloperidol. Cocaine and (+)-methamphetamine engendered full stimulus generalization to MDPV with minimal effects on response rate. LSD produced partial substitution, whereas MDMA and 4-MMC produced complete substitution, and all these serotonergic compounds produced dose-dependent response suppression. (S)-MDPV and α-PVP engendered full substitution with similar potency to the racemate, while (R)-MDPV failed to substitute up to 5 mg/kg. Both Sch 23390 and haloperidol attenuated the discrimination of low MDPV doses and essentially shifted the dose-response curve to the right but failed to block discrimination of the training dose. These findings are generally consistent with previous reports based exclusively on male rodents. Moreover, they confirm the contribution of dopaminergic mechanisms but do not rule out the possible contribution of other neurotransmitter actions to the interoceptive stimulus effects of MDPV.